BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

455 related articles for article (PubMed ID: 25617610)

  • 1. Fabrication of high specificity hollow mesoporous silica nanoparticles assisted by Eudragit for targeted drug delivery.
    She X; Chen L; Velleman L; Li C; Zhu H; He C; Wang T; Shigdar S; Duan W; Kong L
    J Colloid Interface Sci; 2015 May; 445():151-160. PubMed ID: 25617610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overcoming acquired drug resistance in colorectal cancer cells by targeted delivery of 5-FU with EGF grafted hollow mesoporous silica nanoparticles.
    Chen L; She X; Wang T; He L; Shigdar S; Duan W; Kong L
    Nanoscale; 2015 Sep; 7(33):14080-92. PubMed ID: 26242620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel scheme for rapid synthesis of hollow mesoporous silica nanoparticles (HMSNs) and their application as an efficient delivery carrier for oral bioavailability improvement of poorly water-soluble BCS type II drugs.
    Li T; Geng T; Md A; Banerjee P; Wang B
    Colloids Surf B Biointerfaces; 2019 Apr; 176():185-193. PubMed ID: 30616109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hollow Mesoporous Silica Nanoparticles with Tunable Structures for Controlled Drug Delivery.
    Li Y; Li N; Pan W; Yu Z; Yang L; Tang B
    ACS Appl Mater Interfaces; 2017 Jan; 9(3):2123-2129. PubMed ID: 28004570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Shape-Controlled Hollow Mesoporous Silica Nanoparticles with Multifunctional Capping for In Vitro Cancer Treatment.
    Geng H; Chen W; Xu ZP; Qian G; An J; Zhang H
    Chemistry; 2017 Aug; 23(45):10878-10885. PubMed ID: 28580592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hierarchically mesoporous silica nanoparticles: extraction, amino-functionalization, and their multipurpose potentials.
    Du X; He J
    Langmuir; 2011 Mar; 27(6):2972-9. PubMed ID: 21332153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hollow mesoporous silica nanoparticles facilitated drug delivery via cascade pH stimuli in tumor microenvironment for tumor therapy.
    Liu J; Luo Z; Zhang J; Luo T; Zhou J; Zhao X; Cai K
    Biomaterials; 2016 Mar; 83():51-65. PubMed ID: 26773665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A facile route for rapid synthesis of hollow mesoporous silica nanoparticles as pH-responsive delivery carrier.
    Xu H; Zhang H; Wang D; Wu L; Liu X; Jiao Z
    J Colloid Interface Sci; 2015 Aug; 451():101-7. PubMed ID: 25890118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aerosol-Assisted Synthesis of Tailor-Made Hollow Mesoporous Silica Microspheres for Controlled Release of Antibacterial and Anticancer Agents.
    Poostforooshan J; Belbekhouche S; Shaban M; Alphonse V; Habert D; Bousserrhine N; Courty J; Weber AP
    ACS Appl Mater Interfaces; 2020 Feb; 12(6):6885-6898. PubMed ID: 31967774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracellular redox-activated anticancer drug delivery by functionalized hollow mesoporous silica nanoreservoirs with tumor specificity.
    Luo Z; Hu Y; Cai K; Ding X; Zhang Q; Li M; Ma X; Zhang B; Zeng Y; Li P; Li J; Liu J; Zhao Y
    Biomaterials; 2014 Sep; 35(27):7951-62. PubMed ID: 24930850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polydopamine coated hollow mesoporous silica nanoparticles as pH-sensitive nanocarriers for overcoming multidrug resistance.
    Shao M; Chang C; Liu Z; Chen K; Zhou Y; Zheng G; Huang Z; Xu H; Xu P; Lu B
    Colloids Surf B Biointerfaces; 2019 Nov; 183():110427. PubMed ID: 31408782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hierarchical mesoporous silica nanoparticles for tailorable drug release.
    Wu W; Ye C; Xiao H; Sun X; Qu W; Li X; Chen M; Li J
    Int J Pharm; 2016 Sep; 511(1):65-72. PubMed ID: 27374197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coordination-Accelerated "Iron Extraction" Enables Fast Biodegradation of Mesoporous Silica-Based Hollow Nanoparticles.
    Wang L; Huo M; Chen Y; Shi J
    Adv Healthc Mater; 2017 Nov; 6(22):. PubMed ID: 28941142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction of homogenous/heterogeneous hollow mesoporous silica nanostructures by silica-etching chemistry: principles, synthesis, and applications.
    Chen Y; Chen HR; Shi JL
    Acc Chem Res; 2014 Jan; 47(1):125-37. PubMed ID: 23944328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hollow mesoporous silica nanoparticles for tumor vasculature targeting and PET image-guided drug delivery.
    Chakravarty R; Goel S; Hong H; Chen F; Valdovinos HF; Hernandez R; Barnhart TE; Cai W
    Nanomedicine (Lond); 2015; 10(8):1233-46. PubMed ID: 25955122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved Gene Transfer with Functionalized Hollow Mesoporous Silica Nanoparticles of Reduced Cytotoxicity.
    Zhan Z; Zhang X; Huang J; Huang Y; Huang Z; Pan X; Quan G; Liu H; Wang L; Wu AC
    Materials (Basel); 2017 Jun; 10(7):. PubMed ID: 28773087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel drug delivery system of hollow mesoporous silica nanocapsules with thin shells: preparation and fluorescein isothiocyanate (FITC) release kinetics.
    Liu Y; Miyoshi H; Nakamura M
    Colloids Surf B Biointerfaces; 2007 Aug; 58(2):180-7. PubMed ID: 17420116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endogenous NO-release multi-responsive hollow mesoporous silica nanoparticles for drug encapsulation and delivery.
    Wu S; Shi J; Chen X; Bai L; Wu Q; Zhang G
    Colloids Surf B Biointerfaces; 2023 Jul; 227():113346. PubMed ID: 37230051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Engineering hollow mesoporous silica nanoparticles to increase cytotoxicity.
    Pérez-Garnes M; Gutiérrez-Salmerón M; Morales V; Chocarro-Calvo A; Sanz R; García-Jiménez C; García-Muñoz RA
    Mater Sci Eng C Mater Biol Appl; 2020 Jul; 112():110935. PubMed ID: 32409082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy-shaping nanomedicine by loading Calcium Peroxide into Tumor Microenvironment-responsive Nanoparticles for the Antitumor Therapy of Prostate Cancer.
    Wu D; Zhu ZQ; Tang HX; Shi ZE; Kang J; Liu Q; Qi J
    Theranostics; 2020; 10(21):9808-9829. PubMed ID: 32863961
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 23.